account_id none on file
legal_name Entrada Therapeutics, Inc.
ticker TRDA
cik 1689375
domain entradatx.com
linkedin_company_url https://www.linkedin.com/company/entradatx
entry_point_account_id none on file
name Entrada Therapeutics Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 15 executives 1 family 0
why_nownone on file
callsnone on file
filings
General and administrative expenses also include: legal fees relating to intellectual property and corporate matters; professional fees paid for accounting, auditing, consulting and tax services; insurance costs; travel expenses; information technology expenses; and facility costs not otherwise included in research and development expenses.
filing / Aug 5, 2026 / receipt
The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our therapeutics.
filing / Aug 5, 2026 / receipt
healthcare industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular products.
filing / Aug 5, 2026 / receipt
General and administrative expenses also include: legal fees relating to intellectual property and corporate matters; professional fees paid for accounting, auditing, consulting and tax services; insurance costs; travel expenses; information technology expenses; and facility costs not otherwise included in research and development expenses.
filing / May 7, 2026 / receipt
The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our therapeutics.
filing / May 7, 2026 / receipt
healthcare industry and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular products.
filing / May 7, 2026 / receipt
Associate Director, Drug Product Development & Manufacturing | {"ats": "greenhouse", "city": "Boston", "state": "MA", "job_id": "5230341007", "remote": false, "category": "other", "function": "retail"
company_statement / Sep 3, 2026 / receipt
Director, Regulatory Writing | {"ats": "greenhouse", "city": "Boston", "state": "MA", "job_id": "5227238007", "remote": false, "category": "other", "function": "legal", "location": "Boston, MA", "job_
company_statement / Sep 1, 2026 / receipt
Associate Director, Analytical Development & Quality Control | {"ats": "greenhouse", "city": "Boston", "state": "MA", "job_id": "5227648007", "remote": false, "category": "other", "function": "retail"
company_statement / Sep 1, 2026 / receipt
Study Start Up Lead Contractor | {"ats": "greenhouse", "city": "Boston", "state": "MA", "job_id": "5216635007", "remote": false, "category": "other", "function": "other", "location": "Boston, MA", "jo
company_statement / Aug 19, 2026 / receipt
Biostatistician Lead Consultant | {"ats": "greenhouse", "city": "Boston", "state": "MA", "job_id": "5210344007", "remote": false, "category": "other", "function": "other", "location": "Boston, MA", "j
company_statement / Aug 12, 2026 / receipt
Director, Clinical Data Management | {"ats": "greenhouse", "city": "Boston", "state": "MA", "job_id": "5209655007", "remote": false, "category": "other", "function": "clinical", "location": "Boston, M
company_statement / Aug 11, 2026 / receipt
executives
| Nathan J. Dowden | President | - | receipt |
familynone on file
upcoming
| 2026-11-05 | earnings call | scheduled | ir |
changes
| 2024-01-03 | President, appointed | sec_8k |
mcp_package_hint
slug entrada-therapeutics-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$